The emergence of COVID-19 in 2019 has resulted in a significant global health crisis.
Consequently, extensive research was published to understand and mitigate the disease. In …

Purpose: The coronavirus disease 2019 (COVID-19) outbreak, which began in December
2019, has not been completely controlled; therefore, COVID-19 has received much attention …

Purpose The outbreak of COVID-19 has led to a global pandemic with millions of cases and
deaths. Many randomized controlled trials (RCTs) were conducted to establish effective …

Background The coronavirus disease 2019 (COVID-19) pandemic is ravaging the world.
Many therapies have been explored to treat COVID-19. This report aimed to assess the …

Background: Novel coronavirus disease (COVID-19) was first identified in China, which
eventually became a major global health concern due to its pathogenicity and widespread …

Importance SARS-CoV-2 has infected over 200 million people worldwide, resulting in more
than 4 million deaths. Randomized controlled trials are the single best tool to identify …

Introduction The coronavirus disease 2019 (COVID-19) pandemic has been unprecedented
in recent history. The rapid global spread has demonstrated how the emergence of a novel …

Objectives: The aim of this study was to analyze clinical trials using topic modelling to
identify emerging vaccine progression topics around the globe. Methods: The most …

Background The therapeutic evidence collected from well-designed studies is needed to
help manage the global pandemic of the coronavirus disease 2019 (COVID-19). Evaluating …

Background: The COVID-19 pandemic is characterized by an unprecedented urgency to
obtain reliable information on therapeutic options and their evaluation in clinical trials …